Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Synageva BioPharma Corp. (GEVA)

-NMS
78.90 Down 0.48(0.60%) Apr 17, 4:00PM EDT
|After Hours : 78.90 0.00 (0.00%) Apr 17, 4:29PM EDT
Get the big picture on all your investments.
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Net Income (30,736) (28,123) (22,107) (14,484)
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,178  1,899  1,987  1,988  
Adjustments To Net Income2,922  2,679  4,370  1,716  
Changes In Accounts Receivables(231)2,664  (1,213)6  
Changes In Liabilities1,893  2,406  1,582  (3,895)
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(2,421)3,022  (622)(2,482)
Total Cash Flow From Operating Activities (26,395) (15,453) (16,003) (17,151)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(2,307)(4,373)(5,529)(2,412)
Investments(128,680)17,958  17,449  (60,776)
Other Cash flows from Investing Activities933   -  (2,500)(2,868)
Total Cash Flows From Investing Activities (130,054) 13,585   9,420   (66,056)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock1,690  170,987  586  113,089  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 1,690   170,987   586   113,089  
Effect Of Exchange Rate Changes26  (9)(5)(3)
Change In Cash and Cash Equivalents (154,733) 169,110   (6,002) 29,879  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.